Connection

DAVID CORRY to Aspergillosis, Allergic Bronchopulmonary

This is a "connection" page, showing publications DAVID CORRY has written about Aspergillosis, Allergic Bronchopulmonary.
  1. The immune response to airway mycosis. Curr Opin Microbiol. 2021 08; 62:45-50.
    View in: PubMed
    Score: 0.744
  2. Long-Acting Beta Agonists Enhance Allergic Airway Disease. PLoS One. 2015; 10(11):e0142212.
    View in: PubMed
    Score: 0.508
  3. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med. 1997 Mar 17; 185(6):1089-99.
    View in: PubMed
    Score: 0.139
  4. Extravascular inflammation does not increase atherosclerosis in apoE-deficient mice. Biochem Biophys Res Commun. 2009 Jun 19; 384(1):93-9.
    View in: PubMed
    Score: 0.080
  5. Gamma-glutamyl leukotrienase, a novel endothelial membrane protein, is specifically responsible for leukotriene D(4) formation in vivo. Am J Pathol. 2002 Aug; 161(2):481-90.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.